Swedish Orphan Biovitrum262,4SEK -1,06%
Swedish Orphan Biovitrum, also known as Sobi, is an international pharmaceutical company. The company is focused on the research and development of treatments and belonging services for patients with rare diseases. The products are mainly focused on the treatment of inflammatory and genetic diseases. Sobi also markets specialized wound patches under various brands. The head office is located in Stockholm.
Major OwnersSource: Millistream Market Data AB
|Morgan Stanley Smith Barney